Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.

Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR.

Radiat Res. 2013 Jul;180(1):34-43. doi: 10.1667/RR3255.1. Epub 2013 Jun 7.

2.

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.

Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1460-6. doi: 10.1016/j.ijrobp.2010.01.031. Epub 2010 Aug 26.

3.

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TT, Truong P, Ackerman I, Paszat L.

J Clin Oncol. 2008 May 1;26(13):2085-92. doi: 10.1200/JCO.2007.15.2488. Epub 2008 Feb 19.

4.
6.
7.

Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.

Ben-David MA, Elkayam R, Gelernter I, Pfeffer RM.

Isr Med Assoc J. 2016 Mar-Apr;18(3-4):188-92.

8.

Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.

Boström A, Lindman H, Swartling C, Berne B, Bergh J.

Radiother Oncol. 2001 Jun;59(3):257-65.

PMID:
11369066
9.

Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.

Rollmann DC, Novotny PJ, Petersen IA, Garces YI, Bauer HJ, Yan ES, Wahner-Roedler D, Vincent A, Sloan JA, Issa Laack NN.

Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):650-8. doi: 10.1016/j.ijrobp.2015.02.028. Epub 2015 Apr 28.

PMID:
25936812
10.

Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.

Censabella S, Claes S, Orlandini M, Braekers R, Thijs H, Bulens P.

Eur J Oncol Nurs. 2014 Oct;18(5):499-504. doi: 10.1016/j.ejon.2014.04.009. Epub 2014 May 28.

PMID:
24877859
11.

Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.

Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1089-94. doi: 10.1016/j.ijrobp.2011.09.021. Epub 2011 Dec 14.

12.

Sucralfate cream in the management of moist desquamation during radiotherapy.

Delaney G, Fisher R, Hook C, Barton M.

Australas Radiol. 1997 Aug;41(3):270-5.

PMID:
9293679
13.

A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.

Meghrajani CF, Co HS, Arcillas JG, Maaño CC, Cupino NA.

Expert Rev Clin Pharmacol. 2016;9(3):483-91. doi: 10.1586/17512433.2016.1126506. Epub 2016 Jan 9.

PMID:
26619355
14.

Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.

Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, Li X, Meng X, Kong L, Xing L, Yu J.

Br J Radiol. 2016;89(1058):20150665. doi: 10.1259/bjr.20150665. Epub 2015 Nov 26.

PMID:
26607642
15.

Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.

Osako T, Oguchi M, Kumada M, Nemoto K, Iwase T, Yamashita T.

Jpn J Clin Oncol. 2008 May;38(5):334-8. doi: 10.1093/jjco/hyn030. Epub 2008 Apr 16.

16.
17.

Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.

Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, Elias PM, Fritsch PO, Fritsch E.

Br J Dermatol. 2002 Jun;146(6):983-91.

PMID:
12072066
18.

Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study.

Ponten F, Lindman H, Bostrom A, Berne B, Bergh J.

J Natl Cancer Inst. 2001 Jan 17;93(2):128-33.

19.

Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer.

Hemati S, Asnaashari O, Sarvizadeh M, Motlagh BN, Akbari M, Tajvidi M, Gookizadeh A.

Support Care Cancer. 2012 Aug;20(8):1613-8. doi: 10.1007/s00520-011-1250-5. Epub 2011 Oct 19.

PMID:
22006502
20.

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.

Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, Payne D, Bayley A, Ringash J, Kim J, Liu FF, Maxymiw W, Sprague S, Cummings BJ.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):9-13.

PMID:
12182969
Items per page

Supplemental Content

Write to the Help Desk